HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas A Stewart Selected Research

Lymphoma (Lymphomas)

10/2022Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant.
1/2019Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplantation-Eligible Patients.
1/2017Targeting non-Hodgkin lymphoma with blinatumomab.
1/2016Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant.
11/2014Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
5/2012Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience.
12/2011A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
10/2011Primary colorectal lymphoma-clinical outcomes in a population-based series.
6/2009The role of surgical intervention in the management of duodenal lymphoma.
4/2002ALK-positive anaplastic large T-cell lymphoma preceded by Epstein-Barr virus infection complicated by development of an aorto-esophageal fistula.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas A Stewart Research Topics

Disease

13Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2021 - 12/2002
10Lymphoma (Lymphomas)
10/2022 - 04/2002
9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 07/2007
7Neoplasms (Cancer)
01/2022 - 04/2002
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 08/2009
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019 - 11/2011
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018 - 12/2002
4Hodgkin Disease (Hodgkin's Disease)
11/2015 - 02/2012
4Multiple Myeloma
12/2011 - 01/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2011
3Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 02/2012
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2017 - 12/2011
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2015 - 05/2012
2Bronchiolitis Obliterans Syndrome
08/2014 - 09/2010
2Disease Progression
10/2013 - 02/2012
1Breast Neoplasms (Breast Cancer)
01/2019
1Neutropenia
07/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Infections
01/2016
1Virus Diseases (Viral Diseases)
01/2016
1Genomic Instability
09/2010
1Carcinoma (Carcinomatosis)
09/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2010
1Chromosome Aberrations (Chromosome Abnormalities)
07/2009
1Leukemia
07/2007
1Gastrointestinal Hemorrhage (Hematochezia)
04/2002
1Esophageal Fistula
04/2002
1Fistula
04/2002

Drug/Important Bio-Agent (IBA)

10Rituximab (Mabthera)FDA Link
10/2022 - 11/2011
8Busulfan (Busulfex)FDA Link
10/2022 - 07/2007
7Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 07/2007
7thymoglobulinFDA Link
01/2018 - 07/2007
5fludarabineIBA
02/2012 - 07/2007
4Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
10/2022 - 05/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 04/2012
4Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2016 - 07/2007
4obinutuzumabIBA
08/2015 - 03/2012
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
08/2014 - 04/2010
3Etoposide (VP 16)FDA LinkGeneric
06/2015 - 12/2011
2Melphalan (Alkeran)FDA LinkGeneric
10/2022 - 04/2012
2Dacarbazine (DIC)FDA LinkGeneric
06/2015 - 02/2012
2Bleomycin (Blenoxane)FDA LinkGeneric
06/2015 - 02/2012
2Vinblastine (Vinblastine Sulfate)FDA Link
06/2015 - 02/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2015 - 02/2012
1Chimeric Antigen ReceptorsIBA
01/2022
1Synthetic DrugsIBA
08/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2021
1Epirubicin (Ellence)FDA LinkGeneric
01/2019
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1Hormones (Hormone)IBA
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
1Inotuzumab OzogamicinIBA
01/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2017
1blinatumomabIBA
01/2017
1Immunoglobulin A (IgA)IBA
01/2016
1Prednisone (Sone)FDA LinkGeneric
06/2015
1Mechlorethamine (Nitrogen Mustard)FDA Link
06/2015
1Vincristine (Oncovin)FDA LinkGeneric
06/2015
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2014
1N 30IBA
04/2012
1Cisplatin (Platino)FDA LinkGeneric
04/2012
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2011
1Bortezomib (Velcade)FDA Link
12/2011
1IfosfamideFDA LinkGeneric
12/2011
1Carboplatin (JM8)FDA LinkGeneric
12/2011
1IntegrinsIBA
06/2011
1Messenger RNA (mRNA)IBA
06/2011
1Biomarkers (Surrogate Marker)IBA
08/2009
1Lenalidomide (CC 5013)FDA Link
07/2009
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2009
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2009
1plerixaforFDA Link
01/2009
1allogenic effect factor (AEF)IBA
04/2002

Therapy/Procedure

16Therapeutics
01/2022 - 07/2003
13Drug Therapy (Chemotherapy)
01/2022 - 04/2002
13Stem Cell Transplantation
01/2022 - 06/2006
4Autologous Transplantation
01/2019 - 10/2013
4Cell Transplantation
01/2018 - 09/2010
4Radiotherapy
01/2016 - 02/2012
3Transplantation
01/2019 - 10/2013
2Salvage Therapy
01/2018 - 06/2015
1Palliative Care (Palliative Therapy)
01/2022
1Length of Stay
01/2022
1Aftercare (After-Treatment)
10/2021
1Immunomodulation
08/2021
1Adjuvant Chemotherapy
01/2019
1Drug Tapering
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
06/2015
1Radioimmunotherapy
12/2014
1Hematopoietic Stem Cell Transplantation
04/2010
1Homologous Transplantation
07/2007
1Blood Component Removal (Apheresis)
07/2003
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2002
1Organ Transplantation
12/2002